Eledon Pharmaceuticals, Inc.ELDNNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank92
3Y CAGR+11.3%
5Y CAGR+19.5%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+11.3%/yr
vs +14.2%/yr prior
5Y CAGR
+19.5%/yr
Recent deceleration
Acceleration
-2.9pp
Decelerating
Percentile
P92
Near historical high
vs 5Y Ago
2.4x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$16.98M-7.0%
2024$18.25M+48.2%
2023$12.31M-0.1%
2022$12.33M-4.7%
2021$12.94M+85.6%
2020$6.97M+18.6%
2019$5.87M-18.9%
2018$7.24M-34.7%
2017$11.10M-15.3%
2016$13.10M-